patents

Apple Sued for Patent Infringement by Masimo and Affiliate
Apple Sued for Patent Infringement by Masimo and Affiliate
Motley Fool
Apple
Apple Watch
wearables
Cercacor
Masimo
patents
Flag link:
Lilly claims another victory in Alimta patent defence
Lilly claims another victory in Alimta patent defence
Pharmaforum
Eli Lilly
Alimta
patents
generics
Flag link:
The effect of patent expiration on sales of branded competitor drugs in a therapeutic class
The effect of patent expiration on sales of branded competitor drugs in a therapeutic class
Drug Patent Watch
patents
patent expirations
competition
Flag link:
Bristol-Myers Placed A Big Bet On Celgene’s Pipeline. Will It Pay Off For Investors?
Bristol-Myers Placed A Big Bet On Celgene’s Pipeline. Will It Pay Off For Investors?
Motley Fool
Bristol-Myers Squibb
Celgene
M&A
Revlimid
patents
Flag link:
Bristol-Myers wins $752 million in U.S. patent case against Gilead
Bristol-Myers wins $752 million in U.S. patent case against Gilead
Reuters
Bristol-Myers Squibb
Gilead Sciences
Kite Pharma
patents
Juno Therapeutics
Flag link:
Activists seek to block a Gilead patent extension on a lucrative HIV drug
Activists seek to block a Gilead patent extension on a lucrative HIV drug
Stat
Gilead Sciences
patents
HIV
activists
TAF
Flag link:
Will sky-high drug prices spur the US to use an obscure power over patents?
Will sky-high drug prices spur the US to use an obscure power over patents?
Biopharma Dive
drug pricing
patents
NIH
Flag link:
Cellectis gene editing patent upheld in Europe
Cellectis gene editing patent upheld in Europe
Seeking Alpha
gene editing
Europe
Cellectis
patents
Flag link:
Roche's Chugai claims Alexion co-opted its patented tech in building Ultomiris
Roche's Chugai claims Alexion co-opted its patented tech in building Ultomiris
Fierce Pharma
Alexion
Chugai
Roche
Ultomiris
patents
Flag link:
Merck loses bid to revive $2.54 billion patent verdict against Gilead
Merck loses bid to revive $2.54 billion patent verdict against Gilead
Yahoo/Reuters
Merck
Gilead Sciences
patents
hepatitis C
Flag link:
Zimmer Biomet Strikes Out at the US Supreme Court Over Hefty Infringement Award
Zimmer Biomet Strikes Out at the US Supreme Court Over Hefty Infringement Award
Medical Devices and Diagnostics Industry
Zimmer Biomet
Stryker
patents
Supreme Court
devices
Pulsavac Plus
Flag link:
Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection
Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection
Drug Patent Watch
intellectual property
patents
innovation
follow-on
Flag link:
Distorted Drug Patents: Does the U.S. Legal System Steer Researchers Away From Drugs that Take a Long Time to Develop?
Distorted Drug Patents: Does the U.S. Legal System Steer Researchers Away From Drugs that Take a Long Time to Develop?
FDA Law Blog
patents
innovation
drug development
FDA
Flag link:
Why Bausch Health Companies Stock Sank Today
Why Bausch Health Companies Stock Sank Today
Motley Fool
Bausch Health
Novartis
Sandoz
Xifaxan
patents
Flag link:
'I'm quite frankly baffled': Teva's $235M overturn in GSK patent case has judge 'bewildered'
'I'm quite frankly baffled': Teva's $235M overturn in GSK patent case has judge 'bewildered'
Fierce Pharma
Teva Pharmaceutical
GSK
Coreg
patents
Flag link:
Patent Challenge to Alexion Proceeds, But No Amgen Biosimilar Yet
Patent Challenge to Alexion Proceeds, But No Amgen Biosimilar Yet
Xconomy
patents
Alexion
Amgen
biosimilars
USPTO
Flag link:
Why Mallinckrodt Stock Is Plunging Today
Why Mallinckrodt Stock Is Plunging Today
Motley Fool
Mallinckrodt
opioids
patents
Flag link:
Alexion shares slide on Amgen patent challenge to top-seller
Alexion shares slide on Amgen patent challenge to top-seller
Biopharma Dive
Amgen
Alexion
inter partes review
patents
Soliris
Flag link:
Three strategies for managing loss of exclusivity successfully
Three strategies for managing loss of exclusivity successfully
Pharmaforum
market exclusivity
patents
Humalog
Viagra
Eli Lilly
Pfizer
Flag link:
Sanofi, Regeneron score win against Amgen patents on PCSK9 med Repatha
Sanofi, Regeneron score win against Amgen patents on PCSK9 med Repatha
Fierce Pharma
Sanofi
Regeneron
Amgen
PCSK9 inhibitors
patents
Praluent
Repatha
Flag link:

Pages